New perspectives in pharmacological treatment of mild persistent asthma

Drug Discovery Today

Volumn 16, Issue 23-24, 2011, Pages 1084-1091

  Montuschi, Paolo ^a   Barnes, Peter J ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT;

ASTHMA; BRONCHUS HYPERREACTIVITY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; GENE TECHNOLOGY; INFLAMMATION; LUNG FUNCTION TEST; PATIENT CARE; PHARMACEUTICAL CARE; PHENOTYPE; REVIEW; SYMPTOM; TREATMENT RESPONSE;

ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; HUMANS; TREATMENT OUTCOME;

EID: 82255192568     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2011.09.005     Document Type: Review

References (67)

1. P.J. Barnes Mechanisms and resistance in glucocorticoid control of inflammation J. Steroid Biochem. Mol. Biol. 120 2010 76 85
2. R.K. Kandane-Rathnayake Adherence to asthma management guidelines by middle-aged adults with current asthma Thorax 64 2009 1025 1031
3. H.A. Boushey Daily versus as-needed corticosteroids for mild persistent asthma N. Engl. J. Med. 352 2005 1519 1528
4. C.S. Murray Can inhaled corticosteroids influence the natural history of asthma? Curr. Opin. Allergy Clin. Immunol. 8 2008 77 81
5. A. Bush How early do airway inflammation and remodeling occur? Allergol. Int. 57 2008 11 19 (Pubitemid 351413242)
6. Anonymous Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999 Am. J. Respir. Crit. Care Med. 160 1999 2104 2117
7. P. Bakakos Induced sputum in asthma: from bench to bedside Curr. Med. Chem. 18 2011 1415 1422
8. P.E. Silkoff The aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma J. Allergy Clin. Immunol. 114 2004 1241 1256 (Pubitemid 39469172)
9. C.A. Bates, and P.E. Silkoff Exhaled nitric oxide in asthma: from bench to bedside J. Allergy Clin. Immunol. 111 2003 256 262 (Pubitemid 36228543)
10. P.J. Barnes Exhaled nitric oxide in pulmonary diseases: a comprehensive review Chest 138 2010 682 692
11. D. Menzies Portable exhaled nitric oxide measurement: comparison with the 'gold standard' technique Chest 131 2007 410 414 (Pubitemid 46280400)
12. M. Malerba Usefulness of exhaled nitric oxide and sputum eosinophils in the long-term control of eosinophilic asthma Chest 134 2008 733 739
13. A.D. Smith Use of exhaled nitric oxide measurements to guide treatment in chronic asthma N. Engl. J. Med. 352 2005 2163 2173
14. D.E. Shaw The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial Am. J. Respir. Crit. Care Med. 176 2007 231 237 (Pubitemid 47195872)
15. M.W. Pijnenburg Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial Am. J. Respir. Crit. Care Med. 172 2005 831 836 (Pubitemid 41369065)
16. M. Fritsch Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study Pediatr. Pulmonol. 41 2006 855 862 (Pubitemid 44300181)
17. S.J. Szefler Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial Lancet 372 2008 1065 1072
18. J.C. de Jongste Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma Am. J. Respir. Crit. Care Med. 179 2009 93 97
19. H.L. Petsky Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults Cochrane Database Syst. Rev. 4 2009 CD006340
20. P.G. Gibson Inflammatory phenotypes in adult asthma: clinical applications Clin. Respir. J. 3 2009 198 206
21. R.H. Green Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial Lancet 360 2002 1715 1721 (Pubitemid 35447900)
22. L. Jayaram Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations Eur. Respir. J. 27 2006 483 494 (Pubitemid 43372521)
23. H.L. Petsky A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils) Thorax 2010 (Epub ahead of print)
24. P. Haldar Cluster analysis and clinical asthma phenotypes Am. J. Respir. Crit. Care Med. 178 2008 218 224
25. R.H. Green Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids Thorax 57 2002 875 879 (Pubitemid 35178612)
26. A.L. James, and S. Wenzel Clinical relevance of airway remodelling in airway diseases Eur. Respir. J. 30 2007 134 155 (Pubitemid 47074016)
27. P.O. Girodet Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention Pharmacol. Ther. 130 2011 325 337
28. K. Nihlberg Altered matrix production in the distal airways of individuals with asthma Thorax 65 2010 670 676
29. S. Saglani Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers Am. J. Respir. Crit. Care Med. 176 2007 858 864 (Pubitemid 350097074)
30. N. Regamey Increased airway smooth muscle mass in children with asthma, cystic fibrosis, and non-cystic fibrosis bronchiectasis Am. J. Respir. Crit. Care Med. 177 2008 837 843 (Pubitemid 351600661)
31. R. Halwani Airway remodeling in asthma Curr. Opin. Pharmacol. 10 2010 236 245
32. C. Bergeron Airway remodelling in asthma: from benchside to clinical practice Can. Respir. J. 17 2010 e85 e93
33. J.K. Sont Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group Am. J. Respir. Crit. Care Med. 159 1999 1043 1051 (Pubitemid 29202534)
34. C. Ward Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma Thorax 57 2002 309 316 (Pubitemid 34298927)
35. C. Ward Inter-relationships between airway inflammation, reticular basement membrane thickening and bronchial hyper-reactivity to methacholine in asthma; a systematic bronchoalveolar lavage and airway biopsy analysis Clin. Exp. Allergy 35 2005 1565 1571
36. J. Chakir Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-β, IL-11, IL-17, and type I and type III collagen expression J. Allergy Clin. Immunol. 111 2003 1293 1298 (Pubitemid 36683685)
37. E.H. Walters Nonpharmacological and pharmacological interventions to prevent or reduce airway remodelling Eur. Respir. J. 30 2007 574 588 (Pubitemid 351182083)
38. S.M. Puddicombe Involvement of the epidermal growth factor receptor in epithelial repair in asthma FASEB J. 14 2000 1362 1374 (Pubitemid 30439745)
39. E. Cazes Novel anti-inflammatory effects of the inhaled corticosteroid fluticasone propionate during lung myofibroblastic differentiation J. Immunol. 167 2001 5329 5337 (Pubitemid 33009772)
40. S.G. Royce, and M.L. Tang The effects of current therapies on airway remodeling in asthma and new possibilities for treatment and prevention Curr. Mol. Pharmacol. 2 2009 169 181
41. 1 receptor blockade Am. J. Resp. Crit. Care Med. 173 2006 718 728
42. M.M. Kelly Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge Chest 130 2006 741 753 (Pubitemid 44423605)
43. T. Sandström Effects of pharmacological and non-pharmacological interventions Clin. Respir. J. 4 Suppl. 1 2010 41 48
44. R.A. Pauwels Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial Lancet 361 2003 1071 1076 (Pubitemid 36369558)
45. Anonymous Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group N. Engl. J. Med. 343 2000 1054 1063
46. C. Janson The importance of airway remodelling in the natural course of asthma Clin. Respir. J. 4 Suppl. 1 2010 28 34
47. O. Selroos Effect of early vs. late intervention with inhaled corticosteroids in asthma Chest 108 1995 1228 1234
48. T. Haahtela Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma N. Engl. J. Med. 331 1994 700 705 (Pubitemid 24275742)
49. L. Agertoft, and S. Pedersen Effect of long-term treatment with inhaled budesonide on adult height in children with asthma N. Engl. J. Med. 343 2000 1064 1069
50. T.W. Guilbert Long-term inhaled corticosteroids in preschool children at high risk for asthma N. Engl. J. Med. 354 2006 1985 1997
51. H. Bisgaard Intermittent inhaled corticosteroids in infants with episodic wheezing N. Engl. J. Med. 354 2006 1998 2005
52. P. Lange A 15-year follow-up study of ventilatory function in adults with asthma N. Engl. J. Med. 339 1998 1194 1200
53. A. Papi Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma N. Engl. J. Med. 356 2007 2040 2052 (Pubitemid 46789894)
54. M. Turpeinen Daily versus as-needed inhaled corticosteroid for mild persistent asthma (The Helsinki early intervention childhood asthma study) Arch. Dis. Child 93 2008 654 659
55. L.M. van den Toorn Airway inflammation is present during clinical remission of atopic asthma Am. J. Respir. Crit. Care Med. 164 2001 2107 2113 (Pubitemid 34020253)
56. H.Y. Kim The many paths to asthma: phenotype shaped by innate and adaptive immunity Nat. Immunol. 11 2010 577 584
57. P.G. Woodruff T-helper type 2-driven inflammation defines major subphenotypes of asthma Am. J. Respir. Crit. Care Med. 180 2009 388 395
58. P. Montuschi Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications Ther. Adv. Respir. Dis. 1 2007 5 23
59. 4 in exhaled breath condensate Rapid Commun. Mass Spectrom. 18 2004 2723 2729 (Pubitemid 39546004)
60. C.T. Carpenter Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS Chest 114 1998 1653 1659 (Pubitemid 128487489)
61. G. de Laurentiis Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy Eur. Respir. J. 32 2008 1175 1183
62. M. Phillips Variation in volatile organic compounds in the breath of normal humans J. Chromatogr. B: Biomed. Sci. Appl. 729 1999 75 88 (Pubitemid 29264111)
63. F. Röck Electronic nose: current status and future trends Chem. Rev. 108 2008 705 711
64. P. Montuschi Diagnostic performance of an electronic nose, fractional exhaled nitric oxide and lung function testing in asthma Chest 137 2010 790 796
65. N. Fens Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma Am. J. Respir. Crit. Care Med. 180 2009 1076 1082
66. T.R. Bai Evidence for airway remodeling in chronic asthma Curr. Opin. Allergy Clin. Immunol. 10 2010 82 86
67. K. Larsson Monitoring airway remodeling in asthma Clin. Respir. J. 1 4 Suppl. 2010 35 40